Growth Accelerated by Rising Demand for Cancer Treatment Drugs The global Endocrine Therapy Drugs (ETDs) Market

Endocrine Therapy Drugs (ETDs) Market 
 Growth Accelerated by Rising Demand for Cancer Treatment Drugs The global Endocrine Therapy Drugs (ETDs) Market is estimated to be valued at US$ 30434.86 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. ETDs are widely used to treat hormone-related cancers like breast, prostate and endometrial cancer. They help block the hormones known to fuel cancer cell growth. Some common ETDs include tamoxifen, letrozole, anastrozole and exemestane. These drugs are usually taken daily as pills for 5-10 years to prevent cancer recurrence.


Market key trends:
Rising Demand for Cancer Treatment Drugs
The key trend fueling the growth of the ETDs market is the rising prevalence of hormone-related cancers across the globe. According to the World Health Organization (WHO), breast cancer is currently the most common cancer worldwide, with an estimated 2.3 million new cases diagnosed in 2020. The increasing number of patients diagnosed with breast, prostate and endometrial cancer is driving the consumption of ETDs for cancer management and prevention of recurrence. The launch of newer ETD formulations with better efficacy and tolerability is also boosting the market. For instance, in 2020, Novartis received FDA approval for Piqray (alpelisib), a new type II kinase inhibitor for use in combination with fulvestrant for treating hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.
Segment Analysis

The global endocrine therapy drugs (ETDs) market is dominated by hormone therapy segment. Under hormone therapy, selective estrogen receptor modulators (SERMs) account for over 30% of market share as SERM drugs like tamoxifen are a standard initial treatment option and are highly preferred drugs for the management of estrogen receptor positive breast cancer. SERMs help to combat cancer growth by binding to estrogen receptors found on tumor cells and blocking the effects of estrogen on stimulating tumor growth.

Key Takeaways

The global endocrine therapy drugs (ETDs) market demand is expected to witness high growth over the forecast period of 2023 to 2030 driven by rising incidence of hormonal cancers and increasing awareness.

Regional analysis: North America currently accounts for the largest share of the ETDs market owing to increasing diagnosis rates of hormonal cancers and early availability of advanced therapies. Asia Pacific is expected to witness the fastest growth owing to rapidly aging population, adoption of western lifestyles and rising healthcare spending in countries like China and India.

Key players: Key players operating in the endocrine therapy drugs (ETDs) market are Novo Nordisk A/S, AstraZeneca, Generex Biotechnology, Orion Pharma AB, Sanofi, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co.,Inc., Bayer AG, Eli Lilly and Company, Abbott, Tonghua Dongbao Pharmaceutical Co., Ltd., Merck & Co., Inc., TherapeuticsMD, Inc., Pfizer Inc., Allergan, BioSante Pharmaceuticals, Amgen Inc., Noven Pharmaceuticals, Inc., and QuatRx Pharmaceuticals.

Get more insights on this topic: https://www.newswirestats.com/endocrine-therapy-drugs-etds-market-industry-insights-trendsendocrine-therapy-drugs-etds-market-2023-2030/

Comments

Post a Comment

Popular posts from this blog

Increasing aircrafts deliveries to fuel the growth of Aircraft Radome Market

Image
Aircraft Radome Market The global  Aircraft Radome Market is estimated to be valued at US$ 640.7 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Radome is a structural, weatherproof enclosure that protects a radar system or antenna and is transparent to electromagnetic waves. Radomes allow radar systems and antennas to function effectively while protecting them from harsh environmental conditions. In aircrafts, radomes provide structural integrity, aircraft aerodynamic compatibility and protection from heat, wind, and other extreme weather conditions of flight. They are made from advanced composite materials like fiberglass, graphite-epoxy, and thermoplastics. Aircraft radomes have applications in both military as well as commercial aircrafts across a wide range of aircraft platforms. Market key trends: One of the major trends in the b is the growin
Read more

Combined Heat And Power (CHP) Market Growth Accelerated By Increased Adoption Of Decentralized Power Systems

Image
Combined Heat And Power (CHP) Market    Combined heat and power (CHP) systems, also known as cogeneration, are highly efficient systems that generate electricity or mechanical power and capture the heat that would normally be wasted. CHP systems provide numerous advantages such as increased energy efficiency, reduced carbon footprint, and energy cost savings. As energy demands grow globally and concerns over climate change increase, there is a growing emphasis on transitioning to more sustainable and efficient sources of power. The global combined heat and power (CHP) market is estimated to be valued at US$ 31.09 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increased adoption of decentralized power systems is expected to accelerate the growth of the CHP market over the next few years. Decentralized CHP systems are modular in nature and can be instal
Read more

The Health Caregiving Market Is Anticipated To Witness High Growth Owing To Rapid Urbanization And Growing Geriatric Population

Image
  health caregiving market The health caregiving market is concerned with provision of various caregiving services to elderly individuals and people with disabilities. The market caters to needs of the patients by providing home care services such as personal care, emotional support, meal preparation, transportation, light housekeeping, medication reminder, and physical therapy. The demand for elder caregiving services is rising at a significant pace owing to rapid nuclearization of families and increasing number of elderly people with complex care needs. Supportive policy frameworks promoting home-based care and lack of family support further supplements the need for these services. The Global Health Caregiving Market is estimated to be valued at US$ 213.24 Mn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the health caregiving market are Honeywell International Inc., KEMET Corporation (Yageo Compan
Read more